| 2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
| 2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test
| CANCERS |
| 2022 | Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
| FRONTIERS IN ONCOLOGY |
| 2022 | Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN)
| IN VIVO |
| 2022 | PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea | GYNECOLOGIC ONCOLOGY |
| 2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
| 2022 | Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study | GYNECOLOGIC ONCOLOGY |
| 2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | GYNECOLOGIC ONCOLOGY |
| 2022 | Major clinical research advances in gynecologic cancer in 2021
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer
| Obstetrics & Gynecology Science |
| 2022 | ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma
| CELL DEATH & DISEASE |
| 2022 | Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response | CLINICAL CANCER RESEARCH |
| 2021 | Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
| Journal of Menopausal Medicine |
| 2021 | Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor
| ADVANCED SCIENCE |
| 2021 | CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer
| KOREAN JOURNAL OF RADIOLOGY |
| 2021 | Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee | GYNECOLOGIC ONCOLOGY |
| 2021 | Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448 | GYNECOLOGIC ONCOLOGY |
| 2021 | Association between PD-L1 expression and 18 F-FDG uptake in ovarian cancer | ANNALS OF NUCLEAR MEDICINE |
| 2021 | Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY |
| 2021 | A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2021 | Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix | MODERN PATHOLOGY |
| 2021 | Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging
| Obstetrics & Gynecology Science |
| 2021 | Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
| CANCER RESEARCH AND TREATMENT |
| 2021 | Effects of Korean Red Ginseng ( Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial | JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE |
| 2021 | Time for enhancing government-led primary prevention of cervical cancer | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39 + CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2020 | Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
| CANCERS |
| 2020 | Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy | EUROPEAN JOURNAL OF CANCER |
| 2020 | Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
| CANCER RESEARCH AND TREATMENT |
| 2020 | Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancer | SURGICAL ONCOLOGY-OXFORD |
| 2020 | Recommendations for gynecologic cancer care during the COVID-19 pandemic
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Pelvic malakoplakia presenting as endometrial cancer: a case report
| Obstetrics & Gynecology Science |
| 2020 | Major clinical research advances in gynecologic cancer in 2019
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching
| Obstetrics & Gynecology Science |
| 2020 | Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy | JOURNAL OF CLINICAL MEDICINE |
| 2020 | A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
| YONSEI MEDICAL JOURNAL |
| 2020 | Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer | JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
| BMC CANCER |
| 2020 | Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2020 | Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
| 2020 | The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study
| BMC CANCER |
| 2020 | Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
| BMC CANCER |
| 2020 | 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma | HEPATOLOGY |
| 2020 | Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy | INTERNATIONAL JOURNAL OF CANCER |
http://orcid.org/0000-0001-7948-1350
(56191369600)
